Literature DB >> 10634586

Craniofacial pain and motor function: pathogenesis, clinical correlates, and implications.

C S Stohler1.   

Abstract

Many structural, behavioral, and pharmacological interventions imply that favorable treatment effects in musculoskeletal pain states are mediated through the correction of muscle function. The common theme of these interventions is captured in the popular idea that structural or psychological factors cause muscle hyperactivity, muscle overwork, muscle fatigue, and ultimately pain. Although symptoms and signs of motor dysfunction can sometimes be explained by changes in structure, there is strong evidence that they can also be caused by pain. This new understanding has resulted in a better appreciation of the pathogenesis of symptoms and signs of the musculoskeletal pain conditions, including the sequence of events that leads to the development of motor dysfunction. With the improved understanding of the relationship between pain and motor function, including the inappropriateness of many clinical assumptions, a new literature emerges that opens the door to exciting therapeutic opportunities. Novel treatments are expected to have a profound impact on the care of musculoskeletal pain and its effect on motor function in the not-too-distant future.

Entities:  

Mesh:

Year:  1999        PMID: 10634586     DOI: 10.1177/10454411990100040601

Source DB:  PubMed          Journal:  Crit Rev Oral Biol Med        ISSN: 1045-4411


  12 in total

1.  A study on synaptic coupling between single orofacial mechanoreceptors and human masseter muscle.

Authors:  Kemal S Türker; Skjalg E Johnsen; Paul F Sowman; Mats Trulsson
Journal:  Exp Brain Res       Date:  2005-11-23       Impact factor: 1.972

2.  [Influence of botulinum toxin on myogenous facial pain].

Authors:  H Seedorf; R Leuwer; A Bussopulos; C Fenske; H D Jüde
Journal:  Schmerz       Date:  2005-02       Impact factor: 1.107

3.  Anti-Inflammatory Effect of Adipose-Derived Stromal Vascular Fraction on Osteoarthritic Temporomandibular Joint Synoviocytes.

Authors:  Hyungki Kim; Bu-Kyu Lee
Journal:  Tissue Eng Regen Med       Date:  2020-05-04       Impact factor: 4.169

4.  Sustained inflammation induces degeneration of the temporomandibular joint.

Authors:  X D Wang; X X Kou; J J Mao; Y H Gan; Y H Zhou
Journal:  J Dent Res       Date:  2012-03-15       Impact factor: 6.116

5.  The Research Diagnostic Criteria for Temporomandibular Disorders. VI: future directions.

Authors:  Gary C Anderson; Yoly M Gonzalez; Richard Ohrbach; Edmond L Truelove; Earl Sommers; John O Look; Eric L Schiffman
Journal:  J Orofac Pain       Date:  2010

6.  Effects of experimental pain on jaw muscle activity during goal-directed jaw movements in humans.

Authors:  Daraporn Sae-Lee; Terry Whittle; Anna R C Forte; Christopher C Peck; Karen Byth; Barry J Sessle; Greg M Murray
Journal:  Exp Brain Res       Date:  2008-06-13       Impact factor: 1.972

7.  The effect of minocycline on the masticatory movements following the inferior alveolar nerve transection in freely moving rats.

Authors:  Rahman Md Mostafeezur; Hossain Md Zakir; Yoshiaki Yamada; Kensuke Yamamura; Koichi Iwata; Barry J Sessle; Junichi Kitagawa
Journal:  Mol Pain       Date:  2012-04-20       Impact factor: 3.395

8.  Increased levels of intramuscular cytokines in patients with jaw muscle pain.

Authors:  S Louca Jounger; N Christidis; P Svensson; T List; M Ernberg
Journal:  J Headache Pain       Date:  2017-02-27       Impact factor: 7.277

9.  Toll-Like Receptor 4 (TLR4) Stimulates Synovial Injury of Temporomandibular Joint in Rats Through the Activation of p38 Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway.

Authors:  Xuefen Lin; Jianli Xie; Shuzhen Sun; Xusheng Ren; Jingjing Kong; Ping Ji
Journal:  Med Sci Monit       Date:  2018-06-26

Review 10.  Neuron-Glia Crosstalk and Neuropathic Pain: Involvement in the Modulation of Motor Activity in the Orofacial Region.

Authors:  Mohammad Zakir Hossain; Shumpei Unno; Hiroshi Ando; Yuji Masuda; Junichi Kitagawa
Journal:  Int J Mol Sci       Date:  2017-09-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.